UK markets open in 1 hour 19 minutes

Abbott Laboratories (ABTT34.SA)

São Paulo - São Paulo Delayed price. Currency in BRL
Add to watchlist
48.04+1.34 (+2.87%)
At close: 02:08PM BRT
Currency in BRL

Valuation measures4

Market cap (intra-day) 984.63B
Enterprise value 1.03T
Trailing P/E 32.08
Forward P/E 22.17
PEG ratio (5-yr expected) 4.14
Price/sales (ttm)4.46
Price/book (mrq)4.62
Enterprise value/revenue 4.68
Enterprise value/EBITDA 18.15

Trading information

Stock price history

Beta (5Y monthly) 0.74
52-week change 38.55%
S&P500 52-week change 325.87%
52-week high 350.55
52-week low 30.00
50-day moving average 345.75
200-day moving average 344.46

Share statistics

Avg vol (3-month) 3189
Avg vol (10-day) 3285
Shares outstanding 520.88B
Implied shares outstanding 621.08B
Float 81.73B
% held by insiders 10.00%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.69
Forward annual dividend yield 41.47%
Trailing annual dividend rate 32.12
Trailing annual dividend yield 34.54%
5-year average dividend yield 41.36
Payout ratio 454.84%
Dividend date 3N/A
Ex-dividend date 412 Jul 2024
Last split factor 23:1
Last split date 321 Nov 2022

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 13.96%
Operating margin (ttm)15.40%

Management effectiveness

Return on assets (ttm)6.09%
Return on equity (ttm)14.76%

Income statement

Revenue (ttm)40.33B
Revenue per share (ttm)5.80
Quarterly revenue growth (yoy)2.20%
Gross profit (ttm)N/A
EBITDA 10.37B
Net income avi to common (ttm)5.61B
Diluted EPS (ttm)1.46
Quarterly earnings growth (yoy)-7.10%

Balance sheet

Total cash (mrq)6.65B
Total cash per share (mrq)3.82
Total debt (mrq)14.71B
Total debt/equity (mrq)37.66%
Current ratio (mrq)1.60
Book value per share (mrq)22.31

Cash flow statement

Operating cash flow (ttm)7.14B
Levered free cash flow (ttm)4.61B